Keywords: Diabetes, Novo Nordisk, Victoza, Levemir, Bristol-Myers Squibb, AstrraZeneca, Onglyza, Dapagliflozin, Sanofi, Lyxumia, Lantus, Apidra

Highlights from American Diabetes Association meeting

Article | 27 June 2011

Print This

There was a batch of good news coming out of the American Diabetes Association (ADA) 71st annual scientific meeting taking ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in